• gallery image
  • gallery image
  • gallery image

about kinex

Kinex Pharmaceuticals - Buffalo NY Biotechnology Company

Kinex is a specialty pharmaceutical company focused on the development and commercialization of next generation therapies for cancer and immunomodulatory diseases.

Our Company >>

clinical trials

Kinex Pharmaceuticals Clinical Trials

Kinex plans to enter multiple Phase 2 studies with KX01 in 2012. Clinical studies will include castrate-resistant prostate cancer (CRPC), leukemia (CML), ovarian cancer and triple-negative breast cancer (TNB).

Clinical Trials >>

News/Events

Kinex Pharmaceuticals Acquires Rights for Technology and Products from Hanmi Pharmaceuticals, in United States and European Union Territories Monday, December 19th, 2011

Kinex Pharmaceuticals, LLC and Hanmi Pharmaceutical Co., Ltd. announced today the execution of a license agreement from Hanmi Pharmaceuticals granting Kinex Pharmaceuticals

KX2-391 has Entered into Phase 1b Clinical Trial for AML Friday, December 9th, 2011

Kinex Pharmaceuticals has announced that its oncology drug, KX2-391, has entered a clinical trial entitled “A Phase Ib Rising Multiple-Dose Clinical Study

News/Events >>